TG Therapeutics | TGTX - Market Capitalization


TG Therapeutics reported $6.1B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 364.22B 20.46B May/2026
Alaunos Therapeutics USD 5M 5M Sep/2025
Amgen USD 189.89B 13.64B Mar/2026
Arrowhead Research USD 9.7B 920M May/2026
Bayer EUR 37.69B 1.01B May/2026
Biogen USD 26.9B 1.09B Mar/2026
Corcept Therapeutics USD 4.32B 654M Mar/2026
Curis USD 4M 9M May/2026
Gilead Sciences USD 167.39B 5.6B May/2026
Infinity Pharmaceuticals USD 0 0 Apr/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Novartis USD 232.75B 75B May/2026
Novavax USD 1.09B 316M Dec/2025
PTC Therapeutics USD 4.94B 698M May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
TG Therapeutics USD 6.48B 1.18B May/2026
Verastem USD 138M 458M May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026